Patents Assigned to Daiichi Sankyo, Inc.
-
Publication number: 20140186288Abstract: Methods of treating diseases diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-administration of a biguanide and a bile acid sequestrant. Drug products including a biguanide and bile acid sequestrants in combination are also disclosed.Type: ApplicationFiled: March 4, 2014Publication date: July 3, 2014Applicant: Daiichi Sankyo, Inc.Inventor: Michael R. Jones
-
Publication number: 20130344024Abstract: Methods of treating diseases such as diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-administration of a bile acid sequestrant and two or more additional compounds selected from the group consisting of a biguanide, a sulfonylurea and insulin, or pharmaceutically acceptable salts thereof. Drug products including a bile acid sequestrant and two or more additional compounds selected from the group consisting of a biguanide, a sulfonylurea and insulin, or pharmaceutically acceptable salts thereof, in combination are also disclosed.Type: ApplicationFiled: August 27, 2013Publication date: December 26, 2013Applicant: Daiichi Sankyo, Inc.Inventor: Michael R. Jones
-
Publication number: 20130108673Abstract: Methods of treating diseases diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-administration of a biguanide and a bile acid sequestrant. Drug products including a biguanide and bile acid sequestrants in combination are also disclosed.Type: ApplicationFiled: December 4, 2012Publication date: May 2, 2013Applicant: DAIICHI SANKYO, INC.Inventor: DAIICHI SANKYO, INC.
-
Publication number: 20120308511Abstract: Methods of treating diseases such as diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-administration of a bile acid sequestrant and two or more additional compounds selected from the group consisting of a biguanide, a sulfonylurea and insulin, or pharmaceutically acceptable salts thereof. Drug products including a bile acid sequestrant and two or more additional compounds selected from the group consisting of a biguanide, a sulfonylurea and insulin, or pharmaceutically acceptable salts thereof, in combination are also disclosed.Type: ApplicationFiled: August 14, 2012Publication date: December 6, 2012Applicant: Daiichi Sankyo, Inc.Inventor: Michael R. Jones
-
Publication number: 20120177591Abstract: Methods of treating diseases diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co- administration of a biguanide and a bile acid sequestrant. Drug products including a biguanide and bile acid sequestrants in combination are also disclosed.Type: ApplicationFiled: March 20, 2012Publication date: July 12, 2012Applicant: Daiichi Sankyo, Inc.Inventor: Michael R. Jones
-
Publication number: 20100273703Abstract: Methods of treating diseases such as diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-administration of a bile acid sequestrant and two or more additional compounds selected from the group consisting of a biguanide, a sulfonylurea and insulin, or pharmaceutically acceptable salts thereof. Drug products including a bile acid sequestrant and two or more additional compounds selected from the group consisting of a biguanide, a sulfonylurea and insulin, or pharmaceutically acceptable salts thereof, in combination are also disclosed.Type: ApplicationFiled: June 16, 2010Publication date: October 28, 2010Applicant: Daiichi Sankyo, Inc.Inventor: Michael R. Jones
-
Publication number: 20100272671Abstract: Methods of treating diseases diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-administration of a biguanide and a bile acid sequestrant. Drug products including a biguanide and bile acid sequestrants in combination are also disclosed.Type: ApplicationFiled: June 16, 2010Publication date: October 28, 2010Applicant: Daiichi Sankyo, Inc.Inventor: Michael R. Jones